Marvel Biosciences (TSXV:MRVL) Other Long-Term Liabilities : C$0.00 Mil (As of Jul. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Marvel Biosciences Other Long-Term Liabilities?

Marvel Biosciences's other long-term liabilities for the quarter that ended in Jul. 2024 was C$0.00 Mil.

Marvel Biosciences's quarterly other long-term liabilities stayed the same from Jan. 2024 (C$0.00 Mil) to Apr. 2024 (C$0.00 Mil) but then increased from Apr. 2024 (C$0.00 Mil) to Jul. 2024 (C$0.00 Mil).

Marvel Biosciences's annual other long-term liabilities stayed the same from Jul. 2022 (C$0.00 Mil) to Jul. 2023 (C$0.00 Mil) but then increased from Jul. 2023 (C$0.00 Mil) to Jul. 2024 (C$0.00 Mil).

Marvel Biosciences Other Long-Term Liabilities Historical Data

The historical data trend for Marvel Biosciences's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Other Long-Term Liabilities Chart

Marvel Biosciences Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

Other Long-Term Liabilities

Marvel Biosciences Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Other Long-Term Liabilities	Get a 7-Day Free Trial												-	-	-	-	-

Marvel Biosciences Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Marvel Biosciences Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (TSXV:MRVL) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

MBCOF:USA

Address

505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2

Website

https://www.marvelbiotechnology.com

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.

Executives